
v0.7.0
LLM inference in C/C++. Contribute to ggml-org/llama.cpp development by creating an account on GitHub.
Stay updated with the latest developments in Artificial Intelligence

LLM inference in C/C++. Contribute to ggml-org/llama.cpp development by creating an account on GitHub.
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. The US military’s race to make fake blood In February 2007, a US military helicopter carrying blood to a field hospital was shot down in Iraq, killing all seven…
Its call sign was Morphine 1-2. In February 2007, the hulking dual-rotor casualty evacuation helicopter had just flown three wounded soldiers to a field hospital in Balad, north of Baghdad, when another call came: an emergency mission to fly through an insurgent-controlled area in broad daylight.
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Open models have real benefits. Do they outweigh the risks?
MIT Technology Review Explains: Let our writers untangle the complex, messy world of science and technology to help you understand what’s coming next. You can read more from the series here. Late last month, Anthropic released a report arguing that the model GLM-5.3 poses a major cyberattack risk.
When Keelan Miskell began winding down his crypto startup this year, he didn’t think its data was worth much: the users were anonymous, the company just a few years old. But he’s since turned the firm’s digital archives into real money.
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Mars may be a hellhole, but the moon is not far behind The US and China are racing to build bases on the moon, with NASA hoping to establish a small…
Welcome to the second space race. You can be forgiven for experiencing déjà vu. Last time, it was the Soviet Union and the United States vying to be the first to plant some flags.
In a research station in central Panama, you can walk through a century of forest time, watching scrubby plots of adolescent trees give way to cathedral-like canopies of mature growth.
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. We’re putting too much faith in AI’s ability to say no Today’s AI models are trained to refuse a vast number of prompts. If you ask your chatbot how to poison…
The moment Trevor Wischnewsky heard that drones were delivering pizza and sushi around his Texas neighborhood, his mind was made up. “It was super fascinating,” he says.
Ever since people first seriously contemplated giving machines an intelligence modeled on our own, there has never been any question that they would, like us, be able to say no. The sci-fi canon is full of stories of robotic disobedience. Most of these capers are, of course, cautionary.
This week my colleague Antonio Regalado had an interesting update on GLP-1 weight-loss drugs. According to research presented at an aging meeting in Boston, these drugs seem to affect at least some measures of biological age.
Friday, October 16, 2026 Can AI design new life forms? In 2025, Stanford University PhD student Samuel King came up with a preliminary answer when he used a generative AI model to propose genetic blueprints for microscopic viruses.
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. AI breakthroughs in robotics won’t change your life any time soon The hype around humanoid robots is reaching fever pitch.
This week, we released our 2026 version of our Climate Tech Companies to Watch list. It’s an annual project that the MIT Technology Review team puts together.
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Weight-loss drugs show signs of slowing biological aging, say drugmakers Popular weight-loss drugs may do more than help people shed pounds.
Popular weight-loss drugs may do more than help people shed pounds. They might also melt away the years. Drug giants Eli Lilly and Novo Nordisk say patients taking their drugs age less quickly, according to readouts from molecular “aging clocks.” Such clocks assess a person’s biological age by…
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. 10 climate tech companies to watch Each year, MIT Technology Review puts together a list of the most promising climate tech companies in the world.
Showing 18 of 42 stories
Load more storiesGet the top AI news and tools straight to your inbox every week.
Weekly · AI news from MIT Technology Review
Join 15,000+ AI enthusiasts